Claims targeted at DePuy, a unit of Johnson & Johnson, over their ASR hip implant may soon be settled following the announcement of a $4 billion agreement intended to settle…
Read More
In 2010, DePuy recalled two types of hip replacements, the ASR XL Acetabular System and the ASR Hip Resurfacing System. DePuy Orthopaedics is a subsidiary of Johnson & Johnson. DePuy…
Read More
Published May 8, 2012 on TMD A loophole in federal law requires the FDA to approve some previously-recalled medical devices. Now, the agency says it wants to see that changed.…
Read More
In the United Kingdom, the Department of Health and the Medicines and Healthcare Products Regulatory Agency (MHRA) have been collaborating on a safety review of transvaginal mesh. Their collaborative effort…
Read More
On the heels of Johnson & Johnson's loss in a California Superior Court case regarding their DePuy ASR Hip implant, the second DePuy ASR Hip lawsuit started on March 11…
Read More
A recent USA Today editorial piece published on March 24 takes the position that Johnson & Johnson and DePuy mismanaged the development and marketing efforts behind their DePuy ASR Hip…
Read More
A state case regarding the recalled DePuy ASR hip replacement system is scheduled to go to trial in January 2013 in Prince George's County, Maryland. If DePuy does not settle…
Read More
The first trial of 1,800 regarding Johnson & Johnson's defective Gynecare Prolift vaginal mesh was heard in a New Jersey state court in Atlantic City last week. The trial, known…
Read More
The first of 10,000 DePuy ASR Hip lawsuits is on trial in a California Superior Court in Los Angeles County. The trial, Kransky v. DePuy, continues to move forward with…
Read More
On June 28, 2012 the Federal Drug Administration discussed metal-on-metal (MoM) hip systems and highlighted issues relating to local and systemic complications. Health experts concluded there is little reason for…
Read More